Genprex to Present at Upcoming BIO CEO & Investor Conference

February 6, 2024

https://www.prnewswire.com/news-releases/genprex-to-present-at-upcoming-bio-ceo–investor-conference-302054249.html

Presentation to Highlight Company’s Gene Therapies for Cancer and Diabetes

AUSTIN, Texas, Feb. 6, 2024 /PRNewswire/ — Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that its Chief Financial Officer, Ryan Confer, will be providing an overview of the Company’s gene therapies for cancer and diabetes at the upcoming BIO CEO & Investor Conference.

Read more at prnewswire.com

Related news for (GNPX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.